Determinants of Antigenicity and Immunogenicity
Determinants of Antigenicity and Immunogenicity
Determinants of Antigenicity and Immunogenicity
immunogenicity
Molecular entities recognized by lymphocytes
NO2 =
DNP No
Foreignness
Molecular size
Chemical composition and complexity
Ability to be processed and presented by a MHC molecule
1. Contribution of the immunogen to immunogenicity
The more different the
BSA: Bovine serum albumin animal is, the more
probabable is to develope an
inmune reponse
• Foreignness
- +
• Molecular size: The best immunogens tend to
have a molecular mass approaching 100,000
daltons (Da) The higer the size, the higuer
posibility to find a T epitope
MHC = MLA
• Genotype of the host: antigen presentation by MHC products
Algunas personas cuando les vacunan
de Hepatitis B, generan Ab. Otras no lo
hacen. Depende de la genética
PROCESSING
PRESENTATION
Antigen Presentation
processing by MHC molecules
Individual A
Individual B
Route of administration:
o Oral
o Intradermal
o Subcutaneous
o Intramuscular
o Intraperitoneal
o Intravenous
3. Contribution of the biological system to immunogenicity:
Mode of antigen exposure-adjuvants
• Adjuvants Helpers
o Immune stimulants:
↑ co-stimulatory signals
lymphocyte proliferation
Ig + Ag TCR + Ag + MHC
Properties of B-cell epitopes
Conformation: Antibodies
recognize epitopes in native
conformation
not T cells, that
can be
recognized
linear peptides
Properties of B-cell epitopes
Sequence-based methods
for prediction of linear epitopes
TSQDLSVFPLASCCKDNIASTSVTLGCLVTG
YLPMSTTVTWDTGSLNKNVTTFPTTFHETY
GLHSIVSQVTASGKWAKQRFTCSVAHAEST
AINKTFSACALNFIPPTVKLFHSSCNPVGDT
HTTIQLLCLISGYVPGDMEVIWLVDGQKATN
IFPYTAPGTKEGNVTSTHSELNITQGEWVSQ
KTYTCQVTYQGFTFKDEARKCSESDPRGVT
SYLSPPSPL
Posible epitope
location
• Drug design
o Preparation of non-immunogenic drugs